GRIN2B and Cognitive impairment: The results showed that FK506 treatment reduced cognitive impairments, lowered the levels of specific characteristics of postsynaptic deficits, including PSD-95 and NR2B, and reversed the long-term potentiation deficiency and dendritic spine impairments [47].